Status:
COMPLETED
ReVital-CORE Program
Lead Sponsor:
Kessler Foundation
Collaborating Sponsors:
Select Medical
Conditions:
Frailty
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Pilot feasibility study of the ReVital Chemotherapy Online Resiliency Evaluation (CORE) program. As part of standard of care, patients starting a new chemotherapy regimen are referred to complete a pr...
Detailed Description
All patients starting a new chemotherapy regimen will be referred to completed a prehab evaluation with a specialized physical or occupational therapist be and invited to enroll in the ReVital-CORE pr...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- English speaking
- Starting new chemotherapy treatment with oncology partner
- Provide informed consent
Exclusion
- Eligible for hospice care
Key Trial Info
Start Date :
January 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 25 2023
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT04852575
Start Date
January 25 2021
End Date
January 25 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Institute for Rehabilitation
West Orange, New Jersey, United States, 07052